HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ameliorative effect of PN-277 on laser-induced retinal damage.

AbstractBACKGROUND:
The retinal damage induced by laser photocoagulation increases considerably by the secondary degeneration process whereby tissues adjacent to the primary lesion are destroyed. As the neuroprotective effect of immunization by PN-277 was previously demonstrated in models of retina, optic nerve, brain, and spinal cord lesions, it may be used also for reducing retinal damage induced by laser. The aim of this study was to evaluate the neuroprotective effect of immunization with PN-277 in reducing the spread of laser-induced retinal damage.
METHODS:
Standard argon laser lesions were created in 36 DA pigmented rats. Seven days before exposure to laser, the rats were divided into a test group (n = 18) that was pre-immunized with intraperitoneal injection of PN-277 and control group (n = 18) treated with saline. Histological and morphometrical evaluations of the retinal lesions were preformed 3, 20, and 60 days after the injury.
RESULTS:
Significant ameliorative effect was demonstrated in the retinas of the pre-immunized animals 60 days after exposure to laser. The diameter of the lesion was 356 microm as compared with 406 microm (P < 0.01), the cell density of the photoreceptor cell bodies measured in the whole lesion was 72.4% of normal as compared with 64.5% (P = 0.01), and at the center of the lesion it was 57.3% of normal as compared with 38.2% (P < 0.01) (treated and control groups, respectively).
CONCLUSIONS:
Immunization with PN-277 has an ameliorative effect in neural tissue such as the retina. This type of immunization may be of clinical significance in reducing laser-induced retinal injuries in humans.
AuthorsShiri Shulman, Mark Belokopytov, Galina Dubinsky, Michael Belkin, Mordechai Rosner
JournalGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (Graefes Arch Clin Exp Ophthalmol) Vol. 247 Issue 3 Pg. 343-8 (Mar 2009) ISSN: 1435-702X [Electronic] Germany
PMID18987871 (Publication Type: Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Neuroprotective Agents
  • Peptides
  • Glatiramer Acetate
Topics
  • Animals
  • Disease Models, Animal
  • Eye Injuries (etiology, pathology, prevention & control)
  • Glatiramer Acetate
  • Immunosuppressive Agents (therapeutic use)
  • Injections, Intraperitoneal
  • Laser Coagulation (adverse effects)
  • Lasers, Gas (adverse effects)
  • Neuroprotective Agents (therapeutic use)
  • Peptides (therapeutic use)
  • Rats
  • Retina (injuries)
  • Retinal Diseases (etiology, pathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: